Solid lipid microparticle formulations of the pyrethroid gamma-cyhalothrin: incompatibility of the lipid and the pyrethroid and biological properties of the formulationsFREDERIKSEN, Henrik K; KRISTENSEN, Henning G; PEDERSEN, Morten et al.Journal of controlled release. 2003, Vol 86, Num 2-3, pp 243-252, issn 0168-3659, 10 p.Article

Comparison of the lymphatic transport of halofantrine administered in disperse systems containing three different unsaturated fatty acidsHOLM, René; MÜLLERTZ, Anette; PEDERSEN, Gitte P et al.Pharmaceutical research. 2001, Vol 18, Num 9, pp 1299-1304, issn 0724-8741Article

The apparent plasticizing effect of polyethylene glycol (PEG) on the crystallinity of spray dried lactose/PEG compositesMOSEN, Kristina; BÄCKSTRÖM, Kjell; THALBERG, Kyrre et al.European journal of pharmaceutics and biopharmaceutics. 2006, Vol 64, Num 2, pp 206-211, issn 0939-6411, 6 p.Article

Direct estimation of the in vivo dissolution of spironolactone, in two particle size ranges, using the single-pass perfusion technique (Loc-I-Gut®) in humansBØNLØKKE, Lisbet; HOVGAARD, Lars; KRISTENSEN, Henning G et al.European journal of pharmaceutical sciences. 2001, Vol 12, Num 3, pp 239-250, issn 0928-0987Article

Comparison of total oral bioavailability and the lymphatic transport of halofantrine from three different unsaturated triglycerides in lymph-cannulated conscious ratsHOLM, René; MÜLLERTZ, Anette; CHRISTENSEN, Egon et al.European journal of pharmaceutical sciences. 2001, Vol 14, Num 4, pp 331-337, issn 0928-0987Article

Particle formation and capture during spray drying of inhalable particlesMOSEN, Kristina; BÄCKSTRÖM, Kjell; THALBERG, Kyrre et al.Pharmaceutical development and technology. 2004, Vol 9, Num 4, pp 409-417, issn 1083-7450, 9 p.Article

Structured triglyceride vehicles for oral delivery of halofantrine: Examination of intestinal lymphatic transport and bioavailability in conscious ratsHOLM, René; PORTER, Christopher J. H; MÜLLERTZ, Anette et al.Pharmaceutical research. 2002, Vol 19, Num 9, pp 1354-1361, issn 0724-8741, 8 p.Article

Increasing Process Understanding by Analyzing Complex Interactions in Experimental DataNAELAPÄÄ, Kaisa; ALLESØ, Morten; KRISTENSEN, Henning G et al.Journal of pharmaceutical sciences. 2009, Vol 98, Num 5, pp 1852-1861, issn 0022-3549, 10 p.Article

Solid lipid nanoparticles can effectively bind DNA, streptavidin and biotinylated ligandsPEDERSEN, Nina; HANSEN, Susan; HEYDENREICH, Annette V et al.European journal of pharmaceutics and biopharmaceutics. 2006, Vol 62, Num 2, pp 155-162, issn 0939-6411, 8 p.Article

Acoustic monitoring of a fluidized bed coating processNAELAPÄÄ, Kaisa; VESKI, Peep; PEDERSEN, Joan G et al.International journal of pharmaceutics. 2007, Vol 332, Num 1-2, pp 90-97, issn 0378-5173, 8 p.Article

Lymphatic fatty acids in canines dosed with pharmaceutical formulations containing structured triacylglycerolsHOLM, René; PORSGAARD, Trine; PORTER, Christopher J. H et al.European journal of lipid science and technology (Print). 2006, Vol 108, Num 9, pp 714-722, issn 1438-7697, 9 p.Article

Examination of oral absorption and lymphatic transport of halofantrine in a triple-cannulated canine model after administration in self-microemulsifying drug delivery systems (SMEDDS) containing structured triglyceridesHOLM, René; PORTER, Christopher J. H; EDWARDS, Glenn A et al.European journal of pharmaceutical sciences. 2003, Vol 20, Num 1, pp 91-97, issn 0928-0987, 7 p.Article